ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,783.00
-0.71%
S&P ASX All Technology
3,113.80
0.20%
Brent Oil
84.565
0.45%
US Dollar vs AUD
1.50373
-0.08%
Bitcoin
61,209.02
-0.97%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SeaStar Medical Holding Corporation (ICU)

  7. SeaStar Medical Holding Corporation (ICU) News

ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICU
DateTimeSourceHeadlineSymbolCompany
11/06/202422:30GlobeNewswire Inc.SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care NephrologyNASDAQ:ICUSeaStar Medical Holding Corporation
10/06/202422:30GlobeNewswire Inc.SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage CompanyNASDAQ:ICUSeaStar Medical Holding Corporation
07/06/202422:30GlobeNewswire Inc.Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive InflammationNASDAQ:ICUSeaStar Medical Holding Corporation
06/06/202422:30GlobeNewswire Inc.SeaStar Medical Announces 25-for-1 Reverse Stock SplitNASDAQ:ICUSeaStar Medical Holding Corporation
22/05/202422:30GlobeNewswire Inc.Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant EligibilityNASDAQ:ICUSeaStar Medical Holding Corporation
15/05/202406:05GlobeNewswire Inc.SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
30/04/202422:30GlobeNewswire Inc.SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
18/04/202406:00GlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
11/04/202422:30GlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
27/03/202423:30GlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
12/03/202423:30GlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
12/03/202407:05GlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
28/02/202400:30GlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202423:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202423:53GlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
02/02/202400:30GlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
27/01/202400:05GlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
12/01/202408:05GlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
10/01/202400:30GlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
29/12/202300:30GlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
14/12/202300:30GlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
15/11/202308:04GlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
31/10/202323:00GlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
30/10/202323:00GlobeNewswire Inc.FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
18/10/202323:30GlobeNewswire Inc.FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
05/10/202323:30GlobeNewswire Inc.SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023NASDAQ:ICUSeaStar Medical Holding Corporation
04/10/202307:05GlobeNewswire Inc.SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:ICUSeaStar Medical Holding Corporation
29/09/202322:30GlobeNewswire Inc.FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
21/09/202323:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
31/08/202306:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:ICU

Your Recent History

NASDAQ
AMZN
Amazon.com
ASX
WOW
Woolworths
SPI
SP500
S&P 500
ASX
MQG
Macquarie
ASX
ANZ
Australia And New Zealan...
ASX
SUN
Suncorp
FX
GBPAUD
Sterling vs AUD
ASX
XTO
S&P ASX 100
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
ASX
XFL
S&P ASX 50
NASDAQ
GOOGL
Alphabet
ASX
NAB
National Australia Bank
FX
AUDUSD
AUD vs US Dollar
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved